Approval · Notice of Compliance 38385 · 2026
TLANDO: Notice of Compliance 38385
Issued September 29, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38385
- Date
- September 29, 2026
- Company
- Verity Pharmaceuticals IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TLANDO | 02572036 | Approved |
Medicinal ingredients
- TESTOSTERONE UNDECANOATE 112.5 MG per CAP